Epsilon Healthcare Ltd (EPN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.095x

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has a cash flow conversion efficiency ratio of -0.095x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-285.12K ≈ $-201.74K USD) by net assets (AU$2.99 Million ≈ $2.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Epsilon Healthcare Ltd (EPN) net asset quality to measure how much of total assets are equity-financed.

Epsilon Healthcare Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Epsilon Healthcare Ltd to evaluate the quality of earnings relative to operating cash generation.

Epsilon Healthcare Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Epsilon Healthcare Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Adcore Inc TO:ADCO	0.406x
Mecanica Sa Ce RO:MECF	N/A
Heart Test Laboratories Inc. Common Stock NASDAQ:HSCS	-558.107x
InZinc Mining Ltd V:IZN	-0.073x
Equinox Resources Ltd AU:EQN	-0.055x
SECUREKLOUD TECHNOLOGIES LIMITED NSE:SECURKLOUD	0.303x
tokentus investment AG MU:14D	N/A
Jayride Group Ltd AU:JAY	0.082x

Annual Cash Flow Conversion Efficiency for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Epsilon Healthcare Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Epsilon Healthcare Ltd (EPN) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$2.99 Million ≈ $2.11 Million	AU$-3.13 Million ≈ $-2.21 Million	-1.046x	-228.51%
2024-12-31	AU$10.70 Million ≈ $7.57 Million	AU$-3.41 Million ≈ $-2.41 Million	-0.318x	-241.31%
2023-12-31	AU$7.54 Million ≈ $5.33 Million	AU$-703.37K ≈ $-497.68K	-0.093x	+66.36%
2022-12-31	AU$9.27 Million ≈ $6.56 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.277x	+0.04%
2021-12-31	AU$19.57 Million ≈ $13.85 Million	AU$-5.43 Million ≈ $-3.84 Million	-0.277x	+19.21%
2020-12-31	AU$25.32 Million ≈ $17.91 Million	AU$-8.69 Million ≈ $-6.15 Million	-0.343x	+2.43%
2019-12-31	AU$22.32 Million ≈ $15.79 Million	AU$-7.86 Million ≈ $-5.56 Million	-0.352x	-68.97%
2018-12-31	AU$28.09 Million ≈ $19.87 Million	AU$-5.85 Million ≈ $-4.14 Million	-0.208x	-136.88%
2017-12-31	AU$21.36 Million ≈ $15.11 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.088x	-574.77%
2016-12-31	AU$11.34 Million ≈ $8.03 Million	AU$-147.81K ≈ $-104.58K	-0.013x	--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$6.61 Million

AU$9.34 Million AUD

Market Cap Rank

#27994 Global

#1436 in Australia

Share Price

AU$0.02

Change (1 day)

-7.69%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$1.08